COVID-19: COVID-19 public health information from the US CDC | COVID-19 research information from the US NIH | Español | COVID-19 resources for global health researchers

Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional)

Status: Accepting applications

Announcement(s)

Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 Clinical Trials Optional) (PAR-21-344)

Deadlines

Letter of Intent due date: November 20, 2021; November 20, 2022
Application due dates: December 20, 2021; December 20, 2022

Eligibility

Applications from non-domestic entities are restricted to higher education institutions and other non-profit organizations in LMICs, which are defined by The World Bank as low-, lower-middle- or upper-middle-income economies.
Applications from non-domestic entities are restricted to higher education institutions and other non-profit organizations in LMICs, which are defined by The World Bank as low-, lower-middle- or upper-middle-income economies.
View full eligibility details in the program announcements
One or more investigators from an institution in the U.S. and one or more from an institution in an LMIC are strongly encouraged to collaborate on the application.

Updates

No updates at this time.

Program Overview

The purpose of this FOA is to solicit Research Project Grant (R01) applications for up to 3 years of support to develop and test interventions to reduce the impact of HIV-associated stigma on the prevention and treatment of HIV infection and/or AIDS, and on the quality of life of People Living with HIV and/or AIDS (PLWH). The FOA will also support interventions to address the multiple intersecting stigmas and measurement of the stigmas at individual levels.

Proposed collaborative exploratory research is expected to help build the capacity for full research programs by improving the research environment and strengthening LMIC individual and institutional research capabilities in the proposed research areas. Applicants should explicitly address the needs of collaborating LMIC institutions to develop capacity for carrying out research in this field, and plans for sustaining the research activity.

Recent Awards

View a full list of Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in LMICs awards.

Frequently Asked Questions

Review answers to frequently asked questions for applicants to Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional).

Inquiries

Programmatic Issues

Geetha Bansal, Ph.D.
Program Officer
Division of International Training and Research
Fogarty International Center
National Institutes of Health
Building 31, Room B2C39
31 Center Drive, MSC 2220
Bethesda, MD 20892-2220 USA
Phone: 301-496-1492
Fax: 301-402-0779
Email: geetha.bansal@nih.gov

Grants Management

Mollie Shea
Grants Management Specialist
Fogarty International Center
National Institutes of Health
Building 31, Room B2C29
31 Center Drive, MSC 2220
Bethesda, MD 20892-2220
Telephone: 301-496-9750
Fax: 301-594-1211
Email: Mollie.Shea@nih.gov

Partners

This announcement is issued by Fogarty in collaboration with the following NIH Institutes: